Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
about
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal MetastasisEpithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signalingMalignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.Preclinical development of a humanized neutralizing antibody targeting HGF.Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer.The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors.A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models.Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors.Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.Mesothelial to mesenchyme transition as a major developmental and pathological player in trunk organs and their cavities
P2860
Q26783022-FB80075D-0AB0-4DF5-9FB0-EF2ED0B787D0Q33872622-CEFF6863-1C56-467B-A44E-7B829700687EQ37244183-8858B9F6-2BD8-4F57-AE84-924C7423B89FQ37696280-FBA0D97B-082F-4439-BCE8-3CCC186022D0Q37739479-2BC99C2C-7DD1-4C5E-BAA7-C7457AB663EEQ38715123-D69C1BA5-870D-442F-A110-2E14E860AD3FQ38747175-9574FF15-C776-4227-9C1D-564275C5E909Q38824065-8712BC05-6DD2-432F-AEBE-DFA4F1C4297AQ42709077-FD425B2D-C0A9-4516-A65F-A3B434256378Q51110603-9279BC69-7541-493F-A58D-8CA8437CB6EDQ51633169-39C253DF-3BDE-4D20-890A-EA83584EF494Q52858895-A2CC5713-601C-4608-A5A9-9CA41856D88CQ57814182-E75FE91F-683F-4D38-B7A4-27B2FF3435F9
P2860
Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@en
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@nl
type
label
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@en
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@nl
prefLabel
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@en
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@nl
P2093
P2860
P356
P1476
Ovarian cancer ascites enhance ...... t and -independent mechanisms.
@en
P2093
Alain Piché
Claude Laplante
Claudine Rancourt
Denis Lane
Isabelle Matte
Perrine Garde-Granger
P2860
P304
P356
10.1002/IJC.29385
P577
2014-12-18T00:00:00Z